image
ArriVent BioPharma, Inc. Common Stock AVBP
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 18.78
0.643 %
$ 689 M
Market Cap
-4.97
P/E
Price Target Average
79.71%
Revenue Forecast Estimate
-0.00%
EBIT Estimate
18.92%
Net Income Estimate
35.90%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets ArriVent BioPharma, Inc. Common Stock
image
Wall Street analysts predict an average 1-year price target for AVBP of $33.8 , with forecasts ranging from a low of $30 to a high of $36 .
AVBP Lowest Price Target Wall Street Target
30 USD 59.74%
AVBP Average Price Target Wall Street Target
33.8 USD 79.71%
AVBP Highest Price Target Wall Street Target
36 USD 91.69%
Price
Max Price Target
Min Price Target
Average Price Target
36363434323230302828262624242222202018181616Sep '24Sep '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26Jun '26Jun '26Jul '26Jul '26
REVENUE FORECAST

Revenue Forecast Chart AVBP

image
$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)20232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart AVBP

image
$0.0$0.0($10.0m)($10.0m)($20.0m)($20.0m)($30.0m)($30.0m)($40.0m)($40.0m)($50.0m)($50.0m)($60.0m)($60.0m)($70.0m)($70.0m)($80.0m)($80.0m)($90.0m)($90.0m)20232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart AVBP

image
$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.0($50.0m)($50.0m)($100.0m)($100.0m)($150.0m)($150.0m)($200.0m)($200.0m)($250.0m)($250.0m)($300.0m)($300.0m)20232023202420242025202520262026202720272028202820292029